vMethod™ Application for Quantitation of Adalimumab in Human Plasma 1.0

For research use only. Not for use in diagnostic procedures.

Adalimumab plays an extremely important role in treating rhematoid arthritis, psoriatic arthritis, spondylitis, Crohn’s disease, and ulcerative colitis. SCIEX users can implement this method readily and avoid long method development times for biologics.

Learn More

Status: Available Item status information

vMethod Application for Quantitation of Adalimumab in Human Plasma 1.0

Overview

Reduce development time

ActivityUsing an vMethod ApplicationTraditional Method Development
Complete Test Protocol DocumentationIncludedWeeks—Months
Sample Prep TechniquesIncludedWeeks—Months
Optimized MS/MS Acquisition ParametersIncludedDays
LC Instrument Parameters with Retention TimesIncludedDays
Quantitation ParametersIncludedDays
Pre-tested MethodsIncludedDays
Complete test Development and DeploymentIncludedDays
Request information